Iranian Red Crescent Medical Journal

Published by: Kowsar

Maternal Inactive Hepatitis B Status and Birth-Outcomes: A Systematic Review and Meta-Analysis

Elham Ebrahimi 1 , * , Afsaneh Keramat 1 , Masud Yunesian 2 , Seyed-Moayed Alavian 3 , Ahmad Khosravi 4 , Ali Montazeri 5 and Mehrandokht Abedini 6
Authors Information
1 PhD Student in Reproductive Health, Department of Reproductive Health, Student Research Committee,School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, IR Iran
2 Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 MSc of Epidemiology, Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, IR Iran
5 Mental Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, IR Iran
6 Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: November 01, 2016, 18 (11); e31820
  • Published Online: June 12, 2016
  • Article Type: Review Article
  • Received: July 7, 2015
  • Revised: August 4, 2015
  • Accepted: December 1, 2015
  • DOI: 10.5812/ircmj.31820

To Cite: Ebrahimi E, Keramat A, Yunesian M, Alavian S, Khosravi A, et al. Maternal Inactive Hepatitis B Status and Birth-Outcomes: A Systematic Review and Meta-Analysis, Iran Red Crescent Med J. 2016 ; 18(11):e31820. doi: 10.5812/ircmj.31820.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Swindon hepatitis b and c joint strategic needs assessment. 2013;
  • 2. Iran national hepatitis B and C control plan 2012;
  • 3. Wallace J, McNally S, Richmond J. National hepatitis B needs assessment. 2007;
  • 4. Asgari F, Haghazali M. Natural guideline of hepatits B. 2007;
  • 5. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol. 1999; 16(9): 485-8[PubMed]
  • 6. Pastorek JG, Miller JM, Summers PR. The effect of hepatitis B antigenemia on pregnancy outcome. Am J Obstet Gynecol. 1988; 158(3): 486-9
  • 7. Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am. 2011; 40(2): 355-72[DOI][PubMed]
  • 8. Hieber JP, Shorey J, Combes B. Hepatitis and pregnancy. 1977;
  • 9. Medhat A, Shaaban MM, Makhlouf . Acute viral hepatitis in pregnancy. 1993;
  • 10. Mirghani OA, Basama FM. Viral hepatitis in pregnancy. East Afr Med J. 1992; : 445-9
  • 11. Pavel A, Maior E, Cristae A. Detrimental effects of hepatitis B virus infection on the development of the product of conception. 1983;
  • 12. Nayak NC, Datta R. Aetiology and outcome of acute viral hepatitis in pregnancy. J Gastroenterol Hepatol. 1989; 4: 345-52
  • 13. Simms J. Semin Perinatol. Viral hepatitis pregnancy. 1993; : 384
  • 14. Siegel M. Low birth weight and maternal virus diseases. JAMA . 1966; : 568-9
  • 15. Hak AD, Kyun RL. The influence of hepatitis B virus on the fetus in pregnancy. Acta Paediatr J. 1987; : 449-54
  • 16. Vandenbroucke JP, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007; 10(4)
  • 17. Lobstein S, Faber R, Tillmann HL. Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion. 2011; 83(1-2): 76-82[DOI][PubMed]
  • 18. kong D, l.H Y, Bu Y, Yanw H, Hanwe H, Zhaona Q, et al. The effect of chronic hepatitis B virus infection (CHB) during pregnancy on the neonatal growth and development . JMS. 2014; 3(41)
  • 19. Elefsiniotis IS, Brokalaki H, Tsoumakas K. Maternal HBsAg status and infant size: theimportance of viral load and HBsAg quantification. Viral Hepatitis. 2013; 20(444)
  • 20. Lu Y, Chen Y, Xiao X, Liang X, Li J, Huang S, et al. [Impact of maternal hepatitis B surface antigen carrier status on preterm delivery in southern China]. Nan Fang Yi Ke Da Xue Xue Bao. 2012; 32(9): 1369-72[PubMed]
  • 21. moga M, Bagiu N. Is maternal hbs ag carrier status associated with adverse pregnancy outcome? Obstetrics. 2012; 31(19)
  • 22. Reddick KL, Jhaveri R, Gandhi M, James AH, Swamy GK. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat. 2011; 18(7)-8[DOI][PubMed]
  • 23. Lao TT, Leung WC, Ho LF, T KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol. 2007; 1(47): 46-50
  • 24. To WW, Cheung W, Mok KM. Hepatitis B surface antigen carrier status and its correlation to gestational hypertension. Aust N Z J Obstet Gynaecol. 2003; 43(2): 119-22[PubMed]
  • 25. Yang H, C.R. LZ, Zhou G, Zhao Y, Cui D, Li S, et al. Analysis of fetal distress in pregnancy with hepatitis B virus infection. Zhonghua Fu Chan Ke Za Zhi. 2002; 4(37): 211-3
  • 26. Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011; 31(8): 1163-70
  • 27. Lert-amornpong S, Caengow S, Chutaputti A. The association of pregnancy outcomes and HBsAg positive. Thai J Gastroenterol. 2007; 8(3): 115-8
  • 28. MAK SL. Hepatitis b carriers in hong kong: Prevalence and pregnancy outcomes. HKJGOM. 2013; 1(13)
  • 29. Aghamohammadi A. Maternal Hbsag Carrier and Pregnancy Outcome. Austr J Basic App Sci. 2011; 3(5): 607-10
  • 30. Kong D, L.H Y, Bu yi C, Yan W, hu A, Ha W. The effect of chronic hepatitis B virus infection (CHB) during pregnancy on the neonatal growth and development. Fudan Univ Med Sci. 2014; 3(41)
  • 31. Tse KY, Ho LF, Lao TT. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J hepatol. 2005; 43(5): 771-5
  • 32. Sirilert S, Traisrisilp K, Sirivatanapa P, Tongsong T. Pregnancy outcomes among chronic carriers of hepatitis B virus. Int J Gynecol Obs. 2014; 126(2): 106-10
  • 33. Saleh-Gargari S, Hantoushzadeh S, Zendehdel N, Jamal A, Aghdam H. The association of maternal HBsAg carrier status and perinatal outcome. Hepat Mon. 2009; 9(3): 180-4
  • 34. Lao TT, Sahota DS, Suen SS, Law LW, Leung TY. Maternal HBsAg status and infant size--a Faustian bargain? J Viral Hepat. 2012; 19(7): 519-24[DOI][PubMed]
  • 35. Higgins JPT, Green S. The cochrane collaboration. 2008;
  • 36. Borenstein M, Hedges L, Rothstein H. Introduction to meta-analysis. 2007; : 11-21
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments